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Selection for the ability of Saccharomyces cerevisiae cells to take up histidinol, the biosynthetic precursor to
histidine, results in dominant mutations at HOL1. The DNA sequence of HOL1 was determined, and it predicts
a 65-kDa protein related to the major facilitator family (drug resistance subfamily) of putative transport
proteins. Two classes of mutations were obtained: (i) those that altered the coding region of HOL1, conferring
the ability to take up histidinol; and (ii) cis-acting mutations (selected in a mutant HOL1-1 background) that
increased expression of the Hol1 protein. The ability to transport histidinol and other cations was conferred
by single amino acid substitutions at any of three sites located within putative membrane-spanning domains
of the transporter. These mutations resulted in the conversion of a small hydrophobic amino acid codon to a
phenylalanine codon. Selection for spontaneous mutations that increase histidinol uptake by such HOL1
mutants resulted in mutations that abolish the putative start codon of a six-codon open reading frame located
approximately 171 nucleotides downstream of the transcription initiation site and 213 nucleotides upstream of
the coding region of HOL1. This single small upstream open reading frame (uORF) confers translational
repression upon HOL1; genetic disruption of the putative start codon of the uORF results in a 5- to 10-fold
increase in steady-state amounts of Hol1 protein without significantly affecting the level of HOL1 mRNA
expression.

MATERIALS AND METHODS
Strains and media used. Yeast and bacteria used in this study are listed in
Table 1. Growth media and routine genetic techniques were as described by
Sherman et al. (31). YNB AA-His medium lacking histidine was supplemented
with different concentrations of histidinol as required. YNB AA-Ura is a medium
lacking uracil. LS (low salt) medium contains essentially no potassium and was
prepared as previously described (13). KCl was added as needed to obtain the
required concentration of potassium. NaOH and HCl were used to adjust the
final pH of yeast extract-peptone-dextrose (YPD) and YNB media. NH4OH was
used to adjust the final pH of LS media. Solid LiCl was added to media prior to
sterilization. Yeast transformation was performed by treatment of cells with
lithium acetate (17) or by electroporation (4).
Plasmid constructions. Plasmid pMW18, carrying the wild-type HOL1 allele,
was constructed by subcloning the 2.8-kb HindIII-ClaI fragment from pRG167
(12) into the corresponding sites of pRS316 (32). Plasmid pMW13, containing
the HOL1-1 allele, was generated by subcloning the 2.8-kb HindIII-ClaI fragment from pRG174 (12) into plasmid pRG415-2, a URA3-containing centromeric plasmid containing a pUC19-derived polycloning site (11a). The 2.8-kb
HindIII-ClaI fragment from pRG148 (12) carrying the HOL1-1,-101 double
mutant allele was subcloned into pGem7Z (Promega) to produce plasmid
pMW1. Plasmid pMW43, capable of generating the hol1D2 null allele by gamma
deletion (32), was constructed by subcloning the HindIII-EcoRI fragment from
pMW1 and the ClaI-XhoI fragment from pRG131 (12) into the polycloning
region of pRS304 (12). Plasmid pMW62 containing the single HOL1-101 mutation was constructed by replacing the 1,322-bp PvuII-ClaI fragment of pRG148
(12) with the PvuII-ClaI fragment of pMW18. Plasmid pRG165-1 is an integrative plasmid (YIp5) that contains a 1.1-kb HindIII-EcoRI fragment encompassing the 59 portion of HOL1 including the HOL1-101 mutation (12).
Cloning of HOL1 and HOL1-1 alleles. Plasmid pRG158, containing a 400-bp
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lent and divalent cations. This is the first evidence of transport
by this class of transporter in S. cerevisiae, since none of the
physiological substrates of Multidrug Resistance Protein Family 1 is yet known. Second-site mutations that increase HOL1-1
transport-related phenotypes abolish a single small upstream
open reading frame (uORF), resulting in increased steadystate levels of Hol1 protein.

Histidine biosynthesis in Saccharomyces cerevisiae is a multistep pathway in which the final step is the conversion of
histidinol to histidine by histidinol dehydrogenase. Although
histidine auxotrophs defective in upstream steps of this pathway contain histidinol dehydrogenase, they are incapable of
utilizing supplemented histidinol to satisfy their auxotrophic
requirement because of their inability to take up this compound. We previously showed that selection for the ability of S.
cerevisiae cells to take up histidinol led to the isolation of
dominant mutations at the HOL1 locus (12). Although similar
mutations in Salmonella species mapped to the histidine permease (26), the HOL1 locus is genetically distinct from HIP1,
GAP1, and CAN1, loci which encode the permeases that mediate histidine transport in S. cerevisiae (1, 18, 34).
To further characterize the role of HOL1 in transport we
have undertaken a combined molecular and genetic analysis.
HOL1 was found to encode a polytopic membrane protein
related to the Car1/Cyhr family of putative transporters. In S.
cerevisiae the most closely related proteins are those that belong to Multidrug Resistance Protein Family 1 (25). We show
that dominant gain-of-function mutations at HOL1 consist of
single amino acid substitutions in putative membrane-spanning
domains which confer indiscriminate uptake of both monova-
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TABLE 1. S. cerevisiae and E. coli Strainsa
Strain

E. coli
DH5a
JM109

Genotype

F2 f80dlacZDM15 endA1 recA1 hsdR17 supE44 thi-1
gyrA96 relA1 D(lacZYA-argF) U169 l2
endA1 recA1 gyrA96 thi hsdR17 (rk2 mk2) relA1 supE44
D(lac-proAB) [F9 traD36 proAB laqlqZDM15]

S. cerevisiae
MW15 MATa ura3-52 his 3D200 his4-15 trk1D trk2D::HIS3
hol1D1
R757
MATa ura3-52 lys9 his4-15
R657
MATa ura3-52 his4-15 HOL1-1
R704
MATa ura3-52 his4-15 HOL1-1,-101
R1714 MATa ura3-52 trp1D1 his4-15
R1843 MATa ura3-52 trp1D1 his4-15
MW71 MATa ura3-52 trp1D1 his4-15 hol1D2::TRP1
MW72 MATa ura3-52 trp1D1 his4-15 hol1D2::TRP1
MW118 MW15/pHOL1 (pMW18)
MW121 MW15/pHOL1-1,-101 (pMW11)
MW122 MW15/pHOL1-1 (pMW13)
BJ2168 MATa ura3-52 trp1D1 leu2 prc1-401 prb1-1122 pep4-3 gal2
MW137 BJ2168/pCEN-HOL1-1,-101,-6HA (pMW119)
MW150 BJ2168/p2m-HOL1-1,-101,-6HA (pMW117)
MW147 BJ2168/pRS316
LH75
BJ2168/pCEN-HOL1-1,-6HA (pLH18)
a
Strain BJ2168 was a gift from A. Atkins and M. Culbertson. All other S.
cerevisiae strains were generated in our laboratory.

ClaI-XhoI fragment located downstream of the cloned HOL1-1,-101 allele (12),
was integrated into the genomes of wild-type HOL1 (strain R757) and mutant
HOL1-1 (strain R657) cells by transformation. Genomic DNA from these transformants was prepared, digested with HindIII, ligated to recircularize plasmids,
and transformed into Escherichia coli, yielding plasmids pRG167 (HOL1) and
pRG168 (HOL1-1).
Isolation and characterization of new HOL1 mutants. Two strategies were
used to isolate spontaneous mutants that conferred uptake of histidinol. In the
first, single colonies of a wild-type HOL1 strain (R757; Table 1) were allowed to
develop on permissive medium (YPD) and then replica plated to YNB AA-His–
2.5 mM histidinol. To ensure independence of the mutations, only a single Hol1
mutant was picked from a replica-plated colony. Since all of the Hol1 mutants
were dominant, plasmid integration was used to determine which of them harbored alleles of the HOL1 locus. Plasmid pRG165-1 is an integrative plasmid
that contains the 59 portion of HOL1 including the HOL1-101 mutation. For
those Hol1 mutants that harbored a mutation at the HOL1 locus, integration of
pRG165-1 generated a HOL1-X,-101 double mutant that was easily identified by
its ability to grow on a very low concentration (0.25 mM) of histidinol. Seven
independent Hol1 mutants appeared to harbor mutations at HOL1 on the basis
of this preliminary assessment. Plasmids harboring the entire HOL1 region were
recovered from genomic DNA prepared from pRG165-1 integrants by digestion
with XhoI followed by circularization with T4 DNA ligase and transformation
into E. coli. The DNA sequence of the entire HOL1 region for each of the
mutant alleles was determined.
In a second selection, plasmid-borne mutant HOL1 alleles were isolated from
a hol1D2 strain (MW71) that harbored the HOL1-101-expressing centromeric
plasmid pMW62. Independence of mutant alleles was again ensured by picking
only a single mutant that arose from a wild-type colony that was replica plated to
YNB-His–2.5 mM histidinol medium. Mutant HOL1 alleles isolated by this
selection were recovered directly by transformation of genomic DNA preparations into E. coli. The presence of a mutant HOL1 allele on the plasmids
recovered by either of these selection strategies was confirmed by their ability to
confer a Hol1 phenotype to a hol1D2 recipient (strain MW71) upon transformation.
DNA sequence analysis. The DNA sequence of the 2.8-kb fragment containing
the HOL1-1,-101 double mutation was determined from a set of overlapping
deletions generated by exonuclease III (Pharmacia) digestion of plasmid pMW1.
A set of 15 oligonucleotide primers based upon the sequence of the HOL1-1,101-containing fragment was used to determine the DNA sequences of wild-type,
HOL1-1, and other mutant HOL1 alleles. DNA sequencing reactions were performed by the dideoxy-chain termination method (28).
Construction of epitope-tagged Hol1p. To generate a HOL1-1,-101 allele containing multiple copies of the hemagglutinin (HA) epitope (21) a NotI site was
inserted by oligonucleotide-directed mutagenesis immediately following the last
codon in the HOL1 open reading frame. A 118-bp fragment encoding a triple

HA epitope (gift from M. Rose) was subcloned into this site. One clone contained a fortuitous insertion of two correctly oriented copies of this fragment
resulting in the addition of six copies of the epitope. This hextuply-tagged
HOL1-1,-101 allele was recovered and subcloned into centromeric and high-copy
plasmids, creating pRS316-HOL1-1,-101,-6HA (pMW119) and pRS426-HOL11,-101,-6HA (pMW117). Plasmid pLH18, expressing an epitope-tagged HOL1-1
allele, was constructed by replacing the 1.3-kb EcoRI fragment in pMW119
(HOL1-1,-101,-6HA) with that from pMW18 (HOL1).
Immunoblot analysis. S. cerevisiae protein was prepared as described previously (3) and HA-tagged proteins were detected by immunoblotting with monoclonal antibody 12CA5 (Berkeley Antibody Company). To control for protein
loading, Sec61 (33) was detected with a polyclonal antibody (gift from R. Schekman).
Nucleic acid hybridizations. Nucleic acid hybridization analysis was performed
as described by Maniatis et al. (23). Hybridization probes were prepared by
labeling with [a-32P]dCTP using the random oligonucleotide priming method
(10). S. cerevisiae RNA was prepared by disruption of cells in the presence of
glass beads (3) and polyadenylated [poly(A)1] RNA was enriched by retention
on oligo(dT) cellulose columns.
[45Ca21] uptake assays. [45Ca21] was measured by incubating cells in the
presence of CaCl2 at concentrations from 25 mM to 15 mM with a specific
radioactivity of 0.5 mCi/mM of Ca21. Logarithmically growing cells were harvested by centrifugation and washed twice with 50 mM Tris-succinate (pH 5.9)
followed by aeration at 308C for 4 to 6 h in the same buffer, then washed twice
and kept on ice. One milliliter of assay buffer (50 mM Tris-succinate [pH 5.9])
with the appropriate CaCl2 concentration was prewarmed to 308C. An aliquot of
108 cells was added to begin the assay. Samples of 107 cells were removed at
various intervals, collected on 0.45-mM-pore-size filters, and washed three times
with 5 ml of ice-cold buffer. The filters were dried and the amount of radioactivity
contained on each filter was determined by liquid scintillation in a Beckman LS
7000 counter. The values of triplicate assays at each CaCl2 concentration were
averaged. Data are expressed as the initial rate of [45Ca21] uptake over the initial
linear portion of uptake (picomoles per 107 cells per minute) versus the concentration of CaCl2 in the assay buffer.
For competition assays, the rate of [45Ca21] uptake in the presence of a fixed
concentration of CaCl2 (0.5 mM) with 0, 0.5, 2.0, or 5.0 mM CaCl2, MgCl2, or
MnCl2 as competitor was determined. The amount of radioactivity contained in
the cells after 0, 0.5, 2, and 5 min was measured. Results are expressed as percent
transport by division of the initial transport rate in the presence of competitor by
the rate in absence of competitor. The calculated values are plotted with respect
to the concentration of nonradioactive competitor.
Primer extension analysis. Primer extension analysis was performed to determine the 59 end of HOL1 mRNA from congenic HOL1-1 (R657) and HOL1-1,101 (R704) cells (Table 1) essentially as described by Ausubel et al. (3). The
reaction products were separated on a DNA sequencing gel along with the
products of a sequencing reaction using the same oligonucleotide primer. The
59-most nucleotide of oligonucleotide HOL1 PE (59-GGAAGAATAGATGTT
AAATGTGCCAGGAATATAGTCCG-39) corresponds to position 166 with
respect to the HOL1 coding sequence and was used to approximate the transcriptional start site. The 59-most nucleotide of oligonucleotide HOL1 PE3
(59-TTTCGAGAGGAGGTTCAGTAAATATTACTT CAGAGACTG-39) corresponds to position 2274 with respect to the HOL1 coding sequence and was
used to more accurately map the HOL1 transcriptional start site.
Nucleotide accession sequence number. The accession number for the HOL11,-101 sequence is L42348.

RESULTS
HOL1 mutants suppress the K1 requirement of trk1D trk2D
cells. We previously showed that dominant mutations at HOL1
conferred increased uptake of histidinol and sodium (12). To
determine if mutations in HOL1 might also confer increased
K1 transport, the effects of hol1D2, HOL1-1, and HOL1-1,-101
alleles in cells that contained disruptions of the K1 transporter
genes TRK1 and TRK2 were tested. Deletion of TRK1 and
TRK2 severely impairs K1 uptake, resulting in an approximately 1,000-fold increase in the amount of potassium in the
medium required for growth: wild-type cells can grow on media containing 0.1 mM potassium, while trk1D trk2D cells require approximately 30 to 50 mM potassium to support growth
(20).
To determine first if the wild-type Hol1 protein is involved in
potassium transport, the potassium requirements of trk1D
trk2D hol1D2 (MW15) cells expressing the wild-type HOL1
allele from plasmid pMW18 were compared with cells of the
same strain that harbored vector sequences. No significant
differences in the growth rates of these on K1-limiting media
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FIG. 1. Effect of mutations in HOL1 on the phenotype of trk1D trk2D cells.
trk1D trk2D cells bearing vector sequences (pRS316) or the wild-type (HOL1;
pMW18), single mutant (HOL1-1; pMW13), or double mutant (HOL1-1,-101;
pMW11) HOL1 alleles carried on centromeric plasmids were streaked out to
allow development of single colonies on YNB AA-Ura medium containing 7 mM
potassium. Colonies were photographed after growth at 308C for 4 days. See
Table 1 for complete genotypes.

were observed (data not shown). In contrast, when plasmids
expressing the mutant HOL1-1 or HOL1-1,-101 alleles were
introduced into the trk1D trk2D hol1D2 recipient, they partially
suppressed the trk1D trk2D phenotype (Fig. 1). Thus, the mutant Hol1 transporter appears able to transport K1.
Divalent ion uptake by mutant Hol1p. High concentrations
of Ca21 added to the growth medium inhibited the ability of
HOL1-1 and HOL1-1,-101 cells to utilize histidinol and also
suppressed their hypersensitivity to Li1 (unpublished results).
These results suggested that Ca21 might also be transported by
the wild-type or mutant Hol1 proteins. Cells harboring the
hol1D2 mutation or overexpressing the wild-type HOL1 allele
from a multicopy plasmid exhibited essentially indistinguishable rates of Ca21 uptake, suggesting that the wild-type Hol1
protein does not normally transport Ca21 (Fig. 2A). However,
the rate of [45Ca21] uptake by hol1D2 cells expressing the
HOL1-1,-101 allele from a single-copy plasmid was significantly increased compared to hol1D2 cells harboring the vector
alone (Fig. 2A). In separate experiments Mg21 and Mn21 were
shown to be capable of inhibiting [45Ca21] uptake by HOL11,-101 cells in a manner as efficient as isotopic Ca21 (Fig. 2B).
These results suggested that divalent cations in addition to
Ca21 are either transported by HOL1 mutants or can block the
uptake of Ca21.
HOL1 encodes a predicted membrane protein. The DNA
sequence of the 2.8-kb fragment that contains the HOL1-1,101 allele was determined (accession no. L42348) and found to
contain a single large open reading frame of 1,758 nucleotides
which predicts a 586-amino-acid protein with a molecular mass
of 65.2 kDa. Hydrophobicity analysis (9, 16, 22) of the inferred
amino acid sequence of the HOL1 open reading frame identified 12 putative membrane-spanning segments (Fig. 3), suggesting that Hol1 is an integral membrane protein. The putative architecture of Hol1p within the membrane resembles the
commonly observed 12 transmembrane classes of transporters
which include a relatively large hydrophilic region between
putative membrane-spanning domains 6 and 7.
Comparison of the predicted Hol1 protein sequence with
sequences contained in the major databases by using the NCBI
BLASTP network search program revealed that Hol1 shares
sequence similarities with a group of proteins in the Car1/Cyhr
family of putative transporters that include bcr from E. coli (5),
Car1 from Schizosaccharomyces pombe (19), Bmrp from Candida albicans (11), and Cyhr from Candida maltosa (29). A
comparison of the inferred Hol1 sequence with that of Car1
reveals few gaps but only 18% identity (Fig. 4). The inferred
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protein sequences of several other open reading frames in the
genome of S. cerevisiae (ybp3, yb30, yhk8, and ybl8) exhibit
similar degrees of sequence conservation with Hol1. The members of the Cyhr/Car1 family are predicted to contain 12 membrane-spanning domains, and several have been implicated in
the transport of a variety of drugs: E. coli bcr mutants are
hypersensitive to bicyclomycin (5), S. pombe car1 mutants exhibit increased sensitivity to amiloride (19), and S. cerevisiae
cells expressing the C. albicans cyhr gene gain increased resistance to cycloheximide (11). However, to date none of the
normal substrates for any of the members of the Car1/Cyhr
family have yet been identified.
Effect of hol1D null alleles. The DNA sequence of HOL1
revealed that the hol1D mutation generated previously (12)
resulted in an in-frame deletion and thus could express an
altered and perhaps partially functional protein. To better test
the conclusion that HOL1 is a nonessential gene, a deletiondisruption allele, hol1D2, was constructed; this replaced 850
nucleotides of the HOL1 open reading frame with the URA3
gene (see Materials and Methods). The hol1D2 mutation was

FIG. 2. 45Ca uptake by HOL1-1,-101, HOL1-overexpressing, and hol1D2
cells. (A) Uptake of 45Ca was measured in hol1D2 cells and in hol1D2 cells that
harbored plasmids expressing the mutant (HOL1-1,-101) or wild-type (HOL1)
alleles. The wild-type allele was carried on a multicopy plasmid to maximize the
ability to detect transport activity. Total calcium concentration in this experiment
was 0.5 mM. (B) Competition for 45Ca uptake by Ca21, Mg21, and Mn21. Initial
rates of uptake by HOL1-1,-101 cells (strain R704; see Materials and Methods
for details) were measured in the presence and absence of the indicated competitor ions as indicated.
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FIG. 3. Topological analysis and model of inferred protein sequence of HOL1. (A) Hydropathy plot (16) of inferred protein sequence of HOL1 using a window
of six amino acids. Solid bars below hydrophobic peaks indicate putative membrane-spanning domains. Sites of dominant HOL1 mutations are indicated by arrows. (B)
Topological model based on hydrophobicity plot above. Locations and identities of independent HOL1 mutations are indicated at amino acids 191, 509, and 510. L,
leucine; F, phenylalanine; V, valine. See Materials and Methods for details of isolation and identification of mutations.

section confirmed that Hol1 protein is overexpressed when the
HOL1 gene is carried by a multicopy vector. Despite extensive
testing, no growth difference attributable to the presence of a
particular HOL1 allele was found. These tests included those
described by Purnelle et al. (27), sensitivity to extremes of salt
and osmotic conditions, the presence of potentially toxic levels
of various ions, different pH, the use of alternative carbon and
nitrogen sources, the requirement for trace elements and vitamins, and resistance to a variety of compounds, including cy-

FIG. 4. Sequence comparison between Hol1 and two other members of the Car1/Cyhr family of putative transporters. Amino acid sequence alignment between
Hol1, Car1, and Ybp3 was generated using the Pileup program from the collection of programs from the Genetics Computer Group (8).
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generated in cells that harbored the HOL1-1,-101 allele and
resulted in the loss of the Hol1 phenotype in these cells.
Haploid cells containing the hol1D2 allele are viable and show
no obvious growth-related phenotypes (see below).
A physiological role for the wild-type Hol1 protein was
sought by comparing the growth of haploid cells harboring the
wild-type HOL1 allele with those harboring the hol1D2 allele
and those containing the wild-type allele expressed from a
multicopy plasmid (pMW86). Experiments described in a later

cloheximide, amiloride, benomyl, and methotrexate (27). In
addition, the mating efficiency of hol1D2 3 hol1D2 (MW71 3
MW72; Table 1) cells was compared with that of HOL1 3
HOL1 (R1714 3 R1843; Table 1) by the method of Trueheart
et al. (35), and no differences were observed.
HOL1 mutations alter putative membrane-spanning domains. To identify the HOL1-1 and HOL1-101 mutations, the
sequences of wild-type and HOL1-1 alleles carried on plasmids
pMW18 and pMW13, respectively, were determined and compared to the HOL1-1,-101 sequence. These comparisons revealed that the HOL1-1 mutation is a single C-to-T transition
at position 11530 with respect to the start codon converting a
leucine codon to a phenylalanine codon at position 510
(L510F). This site lies within the 11th predicted transmembrane domain (Fig. 3).
The observation that the HOL1-1 mutation affected a putative membrane-spanning domain indicated that this region
might be important for the transport of substrates across the
lipid bilayer. To identify other sites within the Hol1 protein
that may be similarly involved in transport and thus begin to
establish a putative map of the transport pathway through
Hol1, a collection of spontaneous independent HOL1 mutants
was obtained by selecting for the growth of a wild-type HOL1
strain (R757) on medium lacking histidine and supplemented
with 2.5 mM histidinol. Seven mutant HOL1 alleles were
cloned, and their sequences were determined. Two of the
HOL1 mutations were identical to HOL1-1, while another
resulted in a G-to-T transversion at position 11530 which
changed the same leucine codon at position 510 to one for
phenylalanine (L510F) (Fig. 3). Four alleles resulted in G-to-T
transversions at position 11525, resulting in substitution of the
wild-type valine codon for phenylalanine at amino acid position 509 (Fig. 3). The V509F mutation conferred slightly more
vigorous growth on 2.5 mM histidinol than did the L510F
mutation (unpublished results).
We considered that the selection scheme described above
may have been too stringent to identify other mutations that
could also confer permeability to histidinol. To identify additional sites that may be involved in substrate transport, spontaneous independent Hol1 mutants capable of growth on 2.5
mM histidinol were selected from hol1D2 cells that harbored a
centromeric plasmid expressing the HOL1-101 allele upstream
of an otherwise wild-type HOL1 gene (strain MW71). Since
the HOL1-101 mutation increases the efficiency of HOL1
translation (described below), this construct allowed the identification of potentially weaker HOL1 alleles.
The DNA sequences of 13 plasmid-borne HOL1 mutants
isolated by this selection (designated HOL1-Xs) were determined. Nine mutations were similar to the mutations observed in the previous selection which consisted of nucleotide substitutions at codons 509 or 510 that convert them
into phenylalanine codons. The remaining four, however,
resulted in single nucleotide changes that converted a leucine codon to a phenylalanine codon at amino acid position
191 (L191F). L191 is predicted to lie within the fifth membrane-spanning domain (Fig. 3). Consistent with the hypothesis that this selection scheme might identify weaker HOL1
alleles, the L191F mutants are unable to confer growth on
histidinol in the absence of the HOL1-101 mutation (unpublished results).
HOL1 is translationally repressed by a small uORF. Comparison of the DNA sequences of the HOL1-1,-101 and
HOL1-1 clones revealed that the former contained a T-to-A
transversion at position 2214 in the 59 noncoding region. The
location of the HOL1-101 mutation outside of the coding region was consistent with the observation that, by itself, this
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FIG. 5. Detection of HOL1 transcripts. Poly(A)1 RNA was isolated from
BJ2168 HOL1 cells containing either vector (pRS316; strain MW147), HOL11,-6HA (pLH18; strain LH75), or HOL1-1,-101,-6HA (pMW119; strain MW137)
plasmids and probed with a 32P-labeled DNA fragment contained within the
coding region of the HOL1 gene (615-bp KpnI-KpnI; see Fig. 1). HOL1, 2.5-kb
chromosomal HOL1 transcript; HOL1 (6HA), larger transcript from plasmidborne HOL1-1,-6HA or HOL1-1,-101,-6HA alleles; 6HA, hextuply tagged with
influenza HA epitope. See Table 1 for complete genotypes.

mutation does not confer a Hol1 phenotype. Rather, the effect
of the HOL1-101 mutation depends on the presence of a mutation in the coding region of the gene.
To determine if the HOL1-101 mutation had an effect on
steady-state levels of HOL1 mRNA, Northern (RNA) blot
analysis was performed on poly (A)1 RNA isolated from
HOL1 cells containing either a vector control (pRS316) or
plasmids encoding epitope-tagged HOL1-1 or HOL1-1,-101
alleles. The transcripts expressed from centromeric plasmids
encoding epitope-tagged alleles of HOL1 (HOL1-1,-6HA
and HOL1-1,-101,-6HA) were distinguishable from the mRNA
transcribed from the chromosomal wild-type HOL1 gene because of their increased length (Fig. 5). Thus, the chromosomal
HOL1 message served as an internal control in these experiments. Although the chromosomal HOL1 transcripts were
present at slightly lower levels than those expressed from the
plasmids, the levels of HOL1-1,-101,-6HA and HOL1-1,-6HA
RNAs were indistinguishable. This demonstrated that the
stronger Hol1 phenotype conferred upon HOL1-1 cells by the
HOL1-101 mutation is not the result of an increase in the
steady-state levels of the message.
Inspection of the HOL1-101 mutation revealed that it abolished a putative initiation codon for a small uORF of six
codons (Fig. 6). To determine if disruption of the uORF was
responsible for the HOL1-101 phenotype, additional independent mutants similar to HOL1-101 were isolated (see Materials
and Methods). DNA sequence analysis of two additional alleles revealed that one, HOL1-102, resulted in a single nucleotide change of A to G at position 2215 and the other, HOL1105, affected nucleotides 2214 and 2215, resulting in a
nucleotide deletion and a substitution that converted the AT to
a G nucleotide at this position (Fig. 6). Thus, each of three
independent mutations that enhanced the Hol1 phenotype of
HOL1-1 cells abolished the putative translational start site (59
ATG 39) located upstream of the presumed authentic HOL1
initiation codon.
If mutations in the upstream ATG (uATG) affect translation
of HOL1, this site should reside within the RNA transcript.
Primer extension analysis was performed to identify the major
site(s) of transcription initiation. A primer that initiated reverse transcriptase activity at position 166 with respect to the
large HOL1 open reading frame yielded a single extension
product of approximately 350 to 400 nucleotides (unpublished
results). To more accurately determine the site of transcript
initiation, a second primer that initiated reverse transcription
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FIG. 6. DNA sequence of 59 region of HOL1, showing location of HOL1-101,
HOL1-102, and HOL1-105 mutations. uORF is indicated by italics. p, major
transcriptional start site; ATG, first ATG of HOL1 open reading frame.

at position 2274 was used. The size of the extension product in
these experiments indicated that the primary HOL1 transcript
initiates at about position 2384 with respect to the large HOL1
open reading frame (Fig. 7). Template RNA purified from
cells harboring the wild-type uORF and from cells harboring
the HOL1-101 mutation which abolished the putative initiation
codon of the uORF produced similar results. These experiments confirmed that the ATG which is disrupted by the
HOL1-101, HOL1-102, and HOL-105 mutations resides within
HOL1 mRNA.
In one set of experiments in which a greater amount of
labeled primer was added, additional extension products
greater than 500 nucleotides in length were observed (Fig. 7,
compare lanes 1 and 3). Whether these represented authentic
sites of transcription initiation was not determined. Potential
transcription initiation from these sites would not significantly
alter interpretation of the results as they, too, would include
the uORF. In the same experiment an increase in the amount
of extension products obtained from the HOL1-1,-101 template RNA compared to that obtained from the HOL1-1 template RNA was observed (Fig. 7, compare lanes 1 and 3).
However, conclusions regarding levels of steady-state HOL1
mRNA cannot be drawn from these experiments, since they
were not controlled for relative amounts of template RNA.
To determine if the HOL1-101 mutation affected the
amount of steady-state Hol1 protein, plasmids expressing
epitope-tagged versions of the HOL1-1 and HOL1-1,-101 alleles were constructed and Hol1 protein was visualized by
immunoblotting with anti-HA monoclonal antibody. To allow
detection of function of the epitope-tagged protein, the mutant, histidinol transport-competent alleles of HOL1 were incorporated in both constructs. Addition of the epitope tag
resulted in at least partial retention of function, since the
HOL1-1,-101,-6HA allele conferred growth on histidinol media
(unpublished results).
Heterogeneous signals of approximately 68 to 71 kDa were
detected in protein samples from HOL1-1,-6HA- or HOL1-1,101,-6HA-expressing cells (Fig. 8, lanes 2 through 6). Abolition
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FIG. 7. Primer extension analysis of HOL1 transcripts. Poly(A)1 RNA was
isolated from yeast cells and incubated with avian myeloblastosis virus reverse
transcriptase and a 32P-labeled oligonucleotide probe complementary to the
sequence from position 2313 to 2274 of the 59 untranslated region of HOL1.
The size of the cDNA product was determined by comparison with that in a
sequencing reaction using the same primer. See Materials and Methods for
details. Congenic strains, R657 (HOL1-1) and R704 (HOL1-1,-101), were used.

of the putative start codon of the uORF at HOL1 due to the
HOL1-101 mutation resulted in an approximately 5- to 10-fold
increase in the steady-state levels of Hol1 (Fig. 8, lanes 3 and
5). A further increase in Hol1 protein was detected when the
HOL1-1,-101 allele was expressed from a multicopy plasmid
(Fig. 8, lane 6), confirming that expression of HOL1 from a
multicopy plasmid leads to increased HOL1 expression and
indicating that the amount of Hol1 protein from extracts of the

FIG. 8. Disruption of the HOL1 uORF results in increased levels of Hol1
protein. Immunoblot of protein extracts from strains containing vector sequences
only (strain BJ2168; lane 1), centromeric plasmids expressing HOL1-1,-6HA
(strain LH75; lanes 2 and 4), HOL1-1,-101,-6HA (strain MW137; lanes 3 and 5),
or a multicopy plasmid expressing HOL1-1,-101,-6HA (strain MW150). The
epitope-tagged protein was detected with anti-HA monoclonal antibody. Blots
were also probed with antibody against the Sec61 protein to control for the
amount of protein loaded in each well.
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single-copy HOL1-1,-6HA-expressing cells detected on the immunoblot was not saturated. In contrast, no signal was detected when protein extracts from cells that contained only the
vector control were blotted (Fig. 8, lane 1).
DISCUSSION
The product of the HOL1 gene was inferred to be a 586amino-acid polytopic membrane protein that shares limited
identity with a group of putative transporters of the major
facilitator family (also known as the drug translocase family).
Hol1 is most closely related to the Car1/Cyhr subfamily, members of which typically show only limited primary sequence
identities. While these transporters constitute a loose-knit
group, all appear to contain 12 putative membrane-spanning
segments. Hol1 also contains one of the most highly conserved
motifs of the facilitative transporter superfamily, the GR(R/K)
motif located between membrane-spanning domains 2 and 3
(15). Although several members of the Car1/Cyhr subfamily
have been implicated in the transport of hydrophobic drugs,
none of their normal substrates have been identified, and their
role in cell biology remains unknown.
Mutations at HOL1 confer the uptake of histidinol and a
large repertoire of cations and cationic compounds, including
all of the major physiological ions. Although an indirect role
for Hol1 in transport cannot be ruled out, several lines of
evidence support the hypothesis that the mutant Hol1 protein
is a transporter. First, the sequence of Hol1 strongly suggests
that it is an integral membrane protein and the mutations that
confer histidinol and cation uptake always affect putative membrane-spanning domains of Hol1. Second, the dominance of
the transport phenotypes suggests a gain of function more
likely for a transporter than a regulator of transport. In contrast, the hol1D2 mutation does not lead to any of the Hol1
phenotypes. Furthermore, allelic differences in the severity of
the Hol1 phenotype always correlated with severity of the
other transport-related phenotypes, i.e., sensitivity to toxic
ions. Finally, the newly acquired transport activities of HOL1
mutants could be trans-inhibited: the ability to grow on histidinol and the Na1 hypersensitivity phenotype of HOL1 mutants
can be inhibited by Ca21 (unpublished results) and the increased Ca21 uptake could be inhibited by Mg21 or Mn21.
Taken together, the data strongly support the notion that the
gain-of-function phenotypes of HOL1 mutants result from decreased substrate selectivity by Hol1p.
A genetic approach was taken to gain insight into the possible transport pathway through Hol1 that might be taken by
histidinol. Molecular analysis of numerous HOL1 mutations
selected by their ability to confer histidinol transport revealed
a highly limited repertoire of mutable sites within the transporter. The analysis of 21 independent mutants, each selected
for the ability to confer growth on histidinol, revealed structural changes in only 2 of the 12 putative membrane-spanning
domains. Mutations at either V509 or L510 in membranespanning domain 11 confer stronger Hol1 phenotypes than do
mutations at L191 in membrane-spanning domain 5. In every
case, the mutation that conferred the ability to grow on histidinol resulted in a change from a small hydrophobic amino
acid (leucine or valine) to phenylalanine. Thus, while these
mutations preserve the hydrophobicity of the putative membrane-spanning domain, they result in the substitution of a
large side chain for a small one and are consistent with the
hypothesis that the mutations increase permeability through
the Hol1 transporter by decreasing substrate selectivity.
The 12 transmembrane domain superfamily of transporters
that includes the facilitative transporters for glucose, tetracy-
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cline, and xylose have been postulated to have arisen by duplication of an ancestral six transmembrane element (15). Although the Hol1 protein sequence does not contain obvious
repeated sequences within the amino and carboxyl terminal
halves of the protein, the two positions affected by the HOL1
mutation that give rise to histidinol transport would affect
similar positions within analogous membrane-spanning segments in a transporter that consists of two functionally related
halves, and these domains are the two least hydrophobic
among the collection of 12. This is consistent with a model in
which membrane-spanning domains 4 and 10 constitute part of
a polar pathway through which the transported substrate travels. Such an arrangement for the analogous membrane-spanning domains in the superfamily of facilitative transporters,
also known as the USA family because of its inclusion of
uniporters, symporters, and antiporters, has recently been postulated by Goswitz and Brooker (14).
The ability to be converted into a histidinol transporter by
direct selection is not a global property of polytopic membrane
proteins or even of transporters specifically. Despite the analysis of a fairly large collection of independent Hol1 mutants
(12; this report), mutations were not found at genes encoding
other relatives of the Car1/Cyhr transporter family or at genes
encoding permeases capable of transporting histidine. Perhaps
Hol1 mutations in these transporters result in decreased protein stability or the inability to be properly localized to the
plasma membrane. Alternatively, single amino acid substitutions that interfere with the associations of closely packed
transmembrane helices may not generally be sufficient to confer permeability to histidinol. If so, the ability to confer a Hol1
phenotype may be limited to transporters that are nearly capable of transporting histidinol or are even weakly capable of
transporting histidinol prior to mutation. In this case, the Hol1
mutation might simply sufficiently expand the size of cationic
molecules that can be accommodated by the transporter. This
could arise through an increase in the size of the pathway
through which the normal solute travels or by removal of an
electrostatic barrier present in the pore of the wild-type transporter. Either possibility is consistent with the observation that
the mutations that lead to a Hol1 phenotype are predicted to
reside within membrane-spanning domains. However, since
the Hol1 mutations result in a change from a small hydrophobic amino acid to phenylalanine, the removal of an ionic barrier within the pore would have to be an indirect effect of these
mutations on the structure of the transporter.
The energy source that drives the uptake of cations through
the mutant Hol1 transporter is likely to be the large electrical
potential across the plasma membrane. This is supported by
the results of several recent studies. Anderson et al. (2) demonstrated that expression of Kat1, an Arabidopsis K1 channel,
was able to suppress the potassium uptake-defective phenotype of trk1D trk2D cells. Since Kat1 is only activated in Xenopus oocytes under conditions of extreme polarization (approximately 2100 mV [30]) the membrane potential in S. cerevisiae
must be of at least this magnitude. Indeed, Bertl et al. (6) have
shown that a similar membrane hyperpolarization is sufficient
to drive K1 uptake in S. cerevisiae cells that express either the
endogenous Trk proteins or the heterologous Kat1 potassium
channel. Thus, the membrane potential in S. cerevisiae is sufficient to drive the nutritional uptake of cations, provided they
can find a portal of entry. The mutant Hol1 protein appears to
provide this opportunity in a manner that is essentially nonselective.
Expression of the protein encoded by HOL1 is translationally inhibited. The 59 leader of the 2.5-kb HOL1 transcript is
unusually long (approximately 384 nucleotides) compared to
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the average S. cerevisiae leader sequence (52 nucleotides) (7).
This region also contains an uORF of six codons that mediates
a negative effect on the expression of HOL1. Three independent spontaneous mutations obtained by selection for increased Hol1-mediated transport each resulted in the disruption of the putative translational initiation codon of the uORF.
One such mutation, HOL1-101, confers a 5- to 10-fold increase
in steady-state levels of epitope-tagged Hol1 protein. Since
HOL1 mRNA levels are not increased in the HOL1-101 mutants, this strongly suggests that the uORF confers translational repression upon HOL1.
Studies of the effects of uORFs on translation of RNAs
indicate that they may play an important role in translational
control of protein synthesis. For example, S. cerevisiae GCN4
encodes a transcriptional activator of amino acid biosynthetic
genes and has four AUG codons contained within the upstream region of its mRNA (24). In response to amino acid
starvation, translation of GCN4 is increased via trans-acting
factors that modulate utilization of the upstream AUG codons,
resulting in more efficient utilization of the GCN4 start codon
(24). CPA1 mRNA has a single uORF of 25 codons that is
important in translational expression in response to arginine
(36). CPA1 mutations which result in constitutive translational
expression include amino acid codon changes within the uORF
and truncations of the uORF, indicating that the peptide itself
is important in this regulatory mechanism.
Translational regulation in S. cerevisiae has until now been
observed to involve only genes that encode either a biosynthetic enzyme or a regulator of biosynthetic genes; this is the
first time that a putative transporter protein has been found to
be potentially regulated by translational repression. It is also
the first example of spontaneous mutations that relieve translational repression by eliminating the putative start codon of
an uORF. In addition, if HOL1 is indeed regulated by the
uORF, this is a substantially different scenario from that
exemplified by GCN4 (24) or CPA1 (36) because it involves
only a single uORF and one that is most likely too small to
produce a peptide that could participate in the regulatory
mechanism. Elucidation of the conditions under which HOL1
is released from this potential translational repression may
provide important clues regarding the identity of its normal
substrate(s).
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